Page last updated: 2024-08-24

simendan and atrial natriuretic factor

simendan has been researched along with atrial natriuretic factor in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	5 (62.50)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lehtonen, L; Lilleberg, J; Nieminen, MS; Sundberg, S	1
Akkila, J; Hasenfuss, G; Kleber, FX; Lehtonen, LA; Mitrovic, V; Nieminen, MS; Nyquist, O; Remme, WJ	1
Chin, BS; Lip, GY	1
Kivikko, M; Kupari, M; Laine, M; Lilleberg, J; Palkama, T; Pohjanjousi, P	1
Munger, MA	1
Colucci, WS; Finckenberg, P; Haikala, H; Kaheinen, P; Kytö, V; Leskinen, H; Levijoki, J; Louhelainen, M; Merasto, S; Mervaala, EM; Pollesello, P; Vahtola, E	1
Biala, A; Finckenberg, P; Korpi, A; Levijoki, J; Loytainen, M; Martonen, E; Mervaala, E	1
Kim, SH; Park, BM; Yu, L; Yuan, K	1

Reviews

1 review(s) available for simendan and atrial natriuretic factor

Article	Year
New pharmacological strategies for the treatment of heart failure. Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:7 Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atrial Natriuretic Factor; Bosentan; Calcium; Cardiotonic Agents; Clinical Trials as Topic; Endothelin-1; Heart Failure; Humans; Hydrazones; Muscle Proteins; Neprilysin; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Sulfonamides; Tumor Necrosis Factor-alpha	2001

Article

Year

New pharmacological strategies for the treatment of heart failure.

Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:7

Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atrial Natriuretic Factor; Bosentan; Calcium; Cardiotonic Agents; Clinical Trials as Topic; Endothelin-1; Heart Failure; Humans; Hydrazones; Muscle Proteins; Neprilysin; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Sulfonamides; Tumor Necrosis Factor-alpha

2001

Trials

3 trial(s) available for simendan and atrial natriuretic factor

Article	Year
Hemodynamic and neurohumoral effects of levosimendan, a new calcium sensitizer, at rest and during exercise in healthy men. The American journal of cardiology, 1995, May-15, Volume: 75, Issue:15 Topics: Adult; Atrial Natriuretic Factor; Blood Pressure; Calcium; Cardiac Output; Cardiotonic Agents; Catecholamines; Cross-Over Studies; Exercise Test; Heart Rate; Hemodynamics; Humans; Hydrazones; Leg; Male; Pyridazines; Regional Blood Flow; Rest; Simendan; Stroke Volume; Systole; Vascular Resistance; Vasodilator Agents	1995
Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. Journal of the American College of Cardiology, 2000, Nov-15, Volume: 36, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Cardiotonic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Norepinephrine; Pyridazines; Simendan	2000
Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure. European journal of heart failure, 2007, Volume: 9, Issue:1 Topics: Atrial Natriuretic Factor; Cardiotonic Agents; Double-Blind Method; Echocardiography; Female; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Placebos; Pulmonary Circulation; Pyridazines; Simendan; Systole; Time Factors; Ventricular Dysfunction, Left	2007

Other Studies

4 other study(ies) available for simendan and atrial natriuretic factor

Article	Year
Management of acute decompensated heart failure: treatment, controversy, and future directions. Pharmacotherapy, 2006, Volume: 26, Issue:8 Pt 2 Topics: Acute Disease; Atrial Natriuretic Factor; Diuretics; Guideline Adherence; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; Peptide Fragments; Practice Guidelines as Topic; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Vasodilator Agents	2006
Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats. British journal of pharmacology, 2007, Volume: 150, Issue:7 Topics: Animals; Apoptosis; Atrial Natriuretic Factor; Hydrazones; Hypertension; Male; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Norepinephrine; Osteopontin; Pyridazines; Rats; Rats, Inbred Dahl; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Sodium-Calcium Exchanger; Vasodilator Agents; Ventricular Remodeling	2007
Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2011, Volume: 62, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Diet, Sodium-Restricted; Echocardiography; Heart; Heart Failure; Heart Rate; Hydrazones; Hypertension; Kidney; Male; Myocytes, Cardiac; Pyridazines; Rats; Rats, Inbred Dahl; RNA, Messenger; Simendan; Sodium Chloride, Dietary; Sodium, Dietary; Tetrazoles; Valine; Valsartan; Vasodilator Agents; Ventricular Remodeling	2011
Modification of levosimendan-induced suppression of atrial natriuretic peptide secretion in hypertrophied rat atria. European journal of pharmacology, 2018, Jun-15, Volume: 829 Topics: Animals; Atrial Function; Atrial Natriuretic Factor; Atrial Pressure; Calcium; Extracellular Space; Heart Atria; Hemodynamics; Hydrazones; Hypertrophy; Male; Pyridazines; Rats; Rats, Sprague-Dawley; Simendan	2018